The €10 million investment will support the company’s next phase of growth alongside majority shareholders Qualium Investissement and Lauxera
Series A financing, led by M Ventures, highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Chris Major guests on the 'Evaluating Biopharma' podcast for Episode 22: 'Insider’s Advice for Starting, Growing, Exiting a Biotech'.
Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies.
BioProcess360 parent company, Rabbit Run Partners, contributes to Series A Funding Round for Parhelia Biosciences.
